The emergence of viral variants during the course of persistent viral infections is firmly established (2, 5, 6, 8, 32, (36) (37) (38) 41) . This is not surprising since viruses, especially RNA viruses, can undergo rapid mutation. These mutations in the viral genome often produce changes in pathogenicity. Therefore, an understanding of the selective pressures involved in the emergence of viral mutants and identification of the associated genetic changes will provide insights on viral evolution and pathogenesis. To address these issues, we have been studying the evolution of lymphocytic choriomeningitis virus (LCMV) in its natural host. Our previous studies have documented the profound influence of host tissues in the selection of viral variants in carrier mice infected at birth with LCMV (Armstrong strain) (2, 4, 5, 23) . These variants have different biological properties which correlate with their respective tissues of isolation. Most of the central nervous system (CNS) isolates, like the parental Armstrong strain, cause acute infections in adult mice. The virus infection is resolved in -2 weeks as a result of an LCMV-specific cytotoxic T-cell response. In contrast, the majority of the spleen isolates cause chronic infections in adult mice associated with decreased T-cell responses and susceptibility to opportunistic infections (23, 55) . The genomes of these LCMV variants are remarkably conserved (2, 45, 51, 52) . Sequence analysis of several independently derived spleen variants showed >99.8% identity with the parental virus. Very few nucleotide changes leading to amino acid changes were found in both the L and S segments. However, one common change among the spleen isolates was a phenylalanine-to-leucine (F->L) mutation at residue 260 of the glycoprotein which was shown to correlate with the tissuespecific selection and the persistent and immunosuppressive phenotypes of these isolates (2, 28, 29, 44) .
In this study, we have examined the kinetics of the emergence of variants with this F->L amino acid change in the brain, spleen, liver, and kidney of carrier mice infected at birth with the Armstrong strain. We show that there is rapid selection of variants with this mutation in the spleen and liver and a relatively slower selection in the kidney. In contrast, the parental sequence is retained in the majority of the brain isolates analyzed. In addition, most of the isolates with the parental F genotype had a growth advantage in a neuronal cell line GT1-7 compared with isolates with L at glycoprotein residue 260. Thus, these results not only confirm the tissuespecific selection of LCMV variants during chronic infection but also suggest a strong molecular correlation of a single amino acid residue in the glycoprotein with the ability to grow in neuronal cells.
MATERIALS AND METHODS
Mice. BALB/c mice were bred at the University of California at Los Angeles. Neonatally infected carriers were made by injecting 104 PFU of LCMV intracerebrally into mice within 24 h of birth.
Virus. The Armstrong CA1371 strain of LCMV was used in these studies (18) . This original laboratory stock of CA1371 TISSUE-MEDIATED SELECrION OF VIRAL VARIANTS 7491 will be referred to as the parental Armstrong strain. The splenic isolate, clone 13, was isolated from an 8-week-old BALB/c LCMV carrier mouse infected at birth with the Armstrong strain (5) . In this study, LCMV variants from the brain, spleen, liver, and kidney were isolated at different times postinfection (p.i.) from mice infected at birth with the parental Armstrong strain. The organs were harvested, homogenized individually, and titrated on Vero cell monolayers. Wellisolated plaques were picked from each sample and recloned one more time. Virus stocks were grown in BHK-21 cells and used in all experiments at the passage 1 or 2 level.
Virus titration. Infectious LCMV was quantitated by plaque assay on Vero cell monolayers as previously described (5).
Briefly, Vero cells (7.5 x 10O) were plated in 35-mm-diameter wells in six-well dishes (Costar, Cambridge, Mass.). The plates were incubated at 37°C and used the following day for the assay when the cell monolayers were confluent. The medium was removed, and the samples to be titrated were added to the cells (0.2-ml volume). After adsorption for 60 min at 37°C, the cells were overlaid with 3 ml of 0.5% Seakem agarose (FMC Corp., Marine Colloids Div., Rockland, Maine) in medium 199 (GIBCO Laboratories, Grand, Island, N.Y.) supplemented with 5% heat-inactivated fetal calf serum, antibiotics, and L-glutamine. The plates were incubated for 4 days at 37°C and then overlaid with 2.0 ml of 0.5% agarose in medium 199 containing 0.01% neutral red (GIBCO). Plaques were scored the following day.
Cell lines. The GT1-7 cell line was derived from a hypothalamic neuronal tumor in transgenic mice (30) . The gene construct utilized the promoter region of the gonadotropinreleasing hormone (GnRH) gene to express the simian virus 40 T-antigen oncogene. This clonal cell line retains the characteristics of its normal differentiated hypothalamic neuron progenitors since the cells extend neurites, express the endogenous mouse GnRH mRNA, release GnRH in response to polarization, have regulated fast Na+ channels found in neurons, and express neuronal, but not glial, cell markers. The GT1-7 cell line was infected in suspension with LCMV at a multiplicity of infection of 0.2 (107 cells were pelleted and suspended in less than 0.4 ml of virus). After 1 h of adsorption, 2 x 105 cells per well were plated onto 24-well plates. These cells were grown in Dulbecco's modified essential medium with 10% non-heatinactivated fetal calf serum, antibiotics, and L-glutamine. Supernatants were stored and virus titers were determined as described above.
Oligonucleotide hybridization. Virus stocks at the passage 2 level were used to infect BHK-21 cells for guanidinium thiocyanate-CsCl RNA extraction (46) . Total cellular RNAs from these infected cells were used to prepare dot blots and Northern (RNA) blots. For dot blots, 10 ,ug of RNA was denatured with formaldehyde and dotted onto nitrocellulose paper with a 96-hole Bio-Dot apparatus. For Northern blots, 10 ,ug of each of the RNA samples was denatured with formaldehyde and formamide, separated according to size by electrophoresis using a 1.5% agarose gel, and then transferred onto nitrocellulose. Duplicate blots of both preparations were probed with two 20-base-long oligonucleotides (20-mers) which differed only at nucleotide residue 855 (20-mers) , with one base mismatch, that are specific for either the parental sequence (A-like) or the variant sequence (13-like) (see Materials and Methods). Samples A, 13, and C designate RNA from Armstrong-infected, clone 13-infected, and uninfected BHK cells, respectively. Samples 253a and 329a are individually derived spleen isolates (from different mice). 253a was isolated at 150 days p.i., and 329a was isolated at 250 days p.i. Sample 116a was derived from the brain of the same carrier mouse as clone 253a.
nase. Dot blots and Northern blots were prehybridized at 42°C
for at least 2 h with buffer containing 5 x SSPE (lx SSPE is 0.18 M NaCl, 10 mM NaH2PO4, and 1 mM EDTA [pH 7.7]), 5x Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), and 0.1 mg of salmon sperm DNA per ml. Duplicate blots were hybridized with either probe for 24 h at 42°C. These blots were washed with 2x SSPE-0.1% SDS three times for 20 min each time at room temperature and three times for 20 min each time at 54°C, which resulted in complete loss of hybridization for the blots probed with the single mismatch. Viral clones were scored Armstrong-like (F at residue 260) or clone 13-like (L at residue 260), depending on which oligonucleotide probe gave the positive signal.
RESULTS
Screening of isolates for the F->L mutation using oligonucleotide probes with one base mismatch. Mice were injected intracerebrally at birth with 104 PFU of LCMV Armstrong CA1371. These mice were sacrificed on days 7, 16, 32, 150, and 250 p.i., and the brains, spleens, livers, and kidneys were harvested. These tissues were individually homogenized and titrated on Vero cell monolayers. Well-isolated plaques were picked from the plates, and these viral clones were subjected to another cycle of plaque-to-plaque purification. Virus stocks were grown, and total cellular RNA was prepared by the guanidinium isothiocyanate-CsCl procedure. Total cellular RNA was prepared as dot blots or Northern blots. Duplicate blots were probed with 20-base-long oligonucleotides which differed at one position. As shown in Fig. 1 , the probe specific for the parental Armstrong sequence (with F at residue 260) hybridized to the RNA sample from cells infected with the parental virus. On the other hand, the probe specific for the variant sequence (with L at residue 260) hybridized with the RNA samples from cells infected with the splenic variant clone 13. Both probes hybridized specifically to their respective sequences, since each clone showed positive hybridization with one oligonucleotide but no hybridization with the other oligonucleotide on the duplicate blot. RNA from uninfected cells gave no signal with either probe. The LCMV isolates from the brains, spleens, livers, and kidneys of carrier mice were screened by this technique.
Kinetics of emergence of viral variants with the L mutation at amino acid residue 260 of the glycoprotein. We previously showed that the mutation at nucleotide position 855 of the glycoprotein gene, which changes the amino acid at residue 260 from F to L, was found in the vast majority of spleen isolates but not CNS isolates at around 60 days p.i. (2). Here we report that variants with this mutation also predominate in other visceral organs such as the liver, lung, and kidneys of persistently infected mice. However, different kinetic patterns of emergence were observed in these tissues. There was rapid emergence of variants in the spleen, liver, and lung, relatively slower kinetics in the kidney, and retention of the parental F genotype in the brain. Data for the spleen, liver, kidney, and brain are summarized in Fig. 2 a Mice were injected intracerebrally within 24 h of birth with 104 PFU of LCMV Armstrong. These carrier mice were sacrificed at various times p.i., and virus was isolated from the indicated tissues. Plaque-purified isolates were screened for the F--L mutation as described in the legend to Fig. 1 . F, parental Armstrong sequence; L, clone 13 sequence; ND, not done. Fig. 1 .
The level of infectious virus in the spleen and brain at various times after infection was also investigated. At days 7 and 16 p.i., the brain had an approximately 10-fold-greater viral titer compared with the spleen (Fig. 3) . At day 32 p.i., however, the titers switched so that the spleen virus titer became 10-fold greater than the brain titer. This increase of virus levels in the spleen paralleled the emergence of variants with the F->L mutation.
The strong selection for L in the visceral organs was further demonstrated by results obtained from screening isolates from mice coinfected with a 1:1 mixture of the parental Armstrong and spleen variant clone 13 ( Table 2) . As early as 7 days p.i., 100% of the spleen and liver isolates and 78% of the kidney isolates had L at residue 260 of GP-1. By day 27 p.i., all kidney isolates had L. The brain isolates, however, had a 50/50 distribution of the parental and variant genotype up to day 27. Collectively, these results provide direct evidence for the disappearance of one genotype and the emergence of a variant genotype in an organ-specific manner during chronic infection of the natural host.
Growth phenotype of LCMV variants in neuronal cells. Previous studies have shown that LCMV is found predominantly in neurons of persistently infected carrier mice (7, 20, 26, 34, 43) . Therefore, it was of interest to determine if the CNS-derived isolates grew better than the splenic-derived isolates in neuronal cells. A hypothalamic neuronal cell line, GT1-7, was infected with various LCMV isolates, and the amount of infectious virus released in the supernatant was quantitated by a plaque assay. A summary of the data from these experiments is shown in Table 3 . The parental Armstrong strain (a brain-adapted virus) grows well in the neuronal cell line. The majority (five of eight) of the brain isolates analyzed also grew as well as or even better than the parental strain in these cells (P < 0.05). In contrast, the majority (7 of 10) of the spleen isolates analyzed grew poorly in neuronal cells (P < 0.05). Approximately 10-to 80-fold-lower levels of infectious virus were present in these cultures than in those infected with the parental Armstrong strain.
We next determined whether the mutation at residue 260 of the glycoprotein had an effect on the variant's ability to grow in this neuronal cell line. As shown in Table 3 , there is a strong correlation between the presence of parental amino acid F at residue 260 of GP-1 and the ability to grow in neuronal cells. Seven of nine (78%) of the isolates with F replicated efficiently in GT1-7 cells. In contrast, eight of nine (89%) of the isolates with the L mutation had lower virus yield in this neuronal cell Comparison of the growth kinetics between pa] isolates derived from the same carrier mouse furth the strong correlation between the amino acid at r the glycoprotein with the variant's neuronal growl (Fig. 4) . Clones 51a (L) and 56a (F) were isolai same mouse at 16 days p.i., and clones 308 (F) were isolated from another mouse at 250 days p.i. that have F (clones 56a and 308) exhibited enhanc neuronal cells, while those with L (clones 51a and grow as well. The difference in titer is approxi 10-fold between clones 56a and 51a and >50-f clones 308 and 311. It is worth noting that LCM' and 56a, which differ at residue 260, were isolatec after infection of neonatal mice and are likely to t most other loci. These results suggest a stror correlation of a single amino acid residue with abi to grow in neuronal cells.
DISCUSSION
This study confirms and extends our previous r menting the importance of a single amino acid cha residue 260 of GP-1) in the organ-specific selecti( variants during persistent infection of mice (2, 2E study, we have determined the temporal selectio with this mutation in several tissues of carrier mic birth with the parental Armstrong strain of LCM that there is rapid selection of variants with the Fin the spleen and liver, a relatively slower sele kidney, and retention of the parental F genotype Our earlier studies have shown that presence of; at 260 is necessary for enhanced infection of mac 23, 28, 29 The kinetics of emergence of kidney-derived variants with 1311) did not the L mutation is of interest. The kinetics of this mutation is imately 5-to slower than that of the spleen and liver, yet that the kidney fold between receives one-third of the cardiac output and the blood at this V clones 51a time contains mostly variants with the L mutation (la, 32). At I just 16 days day 32 p.i., approximately half of the kidney isolates still retain )e isogenic at the F genotype, whereas all of the spleen and liver isolates have ig molecular the L genotype. In the kidney, the virus is located mostly in the ility of a virus glomeruli and tubules (11, 31, (35) (36) (37) 54) . Virus present in the glomeruli is in the form of infectious virus-immunoglobulin G complexes. Carrier mice contain LCMV-specific antibodies which complex with the variants in the circulation, resulting in deposition and entrapment of these infectious virus-immunoreports docuglobulin G complexes in the glomeruli. Alternatively, growth of inge (F->L at the virus in the renal tubules may also be important in the on of LCMV selection of these variants. The tubules are of particular 3, 29) . In this interest, since the presence of different pHs in the ascending n of variants and descending limbs may affect the growth of particular ce infected at variants. In this context, it is worth noting that the F->L V. We found mutation is near the putative cleavage site of the glycoprotein -+L mutation precursor and that the GP-1 and GP-2 are homotetramers that -ction in the are noncovalently linked and contain no disulfide bonds (12, in the brain. 13 ). The L mutation may affect the noncovalent binding of amino acid L these two proteins such that a change in pH may favor better orophages ( (15, 17, 19, 25, 48, 53) . Moreover, the replicative capacity and cell tropism of HIV have also been shown to change after passage through some established cell lines (16, 39) . This altered host range is linked to differences in the glycosylation pattern of the viral envelope glycoprotein. In fact, amino acid changes in the V3 loop of HIV gp120 have been shown to be involved in both macrophage and T-cell tropism (14, 49, 50 
